K. Maiese et al., NEUROPROTECTION OF LUBELUZOLE IS MEDIATED THROUGH THE SIGNAL-TRANSDUCTION PATHWAYS OF NITRIC-OXIDE, Journal of neurochemistry, 68(2), 1997, pp. 710-714
Neuronal survival after ischemic injury is determined through the indu
ction of several biological pathways. We examined whether lubeluzole,
an agent efficacious in both clinical and experimental models of cereb
ral ischemia, modulated the signal transduction mechanisms of nitric o
xide (NO), a downstream mediator of anoxic neurodegeneration. Both pre
treatment [NO survival = 23 +/- 3%, NO/lubeluzole (750 nM) survival =
63 +/- 2%, p < 0.001] and coadministration [NO survival = 25 +/- 3%, N
O/lubeluzole (750 nM) survival = 59 +/- 3%, p < 0.001] of lubeluzole w
ith NO generators equally protected cultured hippocampal neurons in a
dose-dependent manner against the toxic effects of NO, suggesting that
the agent protects by acutely modifying toxic cellular pathways rathe
r than preconditioning the neuron before injury. The protection observ
ed with lubeluzole was stereospecific but was not limited to pre- or c
oadministration. Lubeluzole also was found to significantly protect ag
ainst the toxicity of NO for a period of 4-6 h after NO exposure [NO s
urvival = 31 +/- 2%, NO/lubeluzole (750 nM) survival at 6 h = 56 +/- 3
%, p < 0.001]. We conclude that the neuroprotective ability of lubeluz
ole is unique and involves the direct modulation of the NO pathway, In
addition, the mechanisms of NO toxicity are dynamic and reversible pr
ocesses that, if left unaltered, will lead to neuronal injury, Further
investigation of the downstream signal transduction mechanisms below
the level of NO generation may elucidate the specific cellular events
responsible for neurodegeneration.